Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial
This subgroup analysis of the ASCEND-D trial demonstrated comparable efficacy and safety of daprodustat versus darbepoetin alfa in PD patients, supporting its use in the treatment of anemia in these patients.
Authors
- Brian Rayner (ORCID: https://orcid.org/0000-0002-0167-9591)
- Amy M. Meadowcroft (ORCID: https://orcid.org/0000-0002-5934-0136)
- Michael Aarup (ORCID: https://orcid.org/0000-0002-2645-9886)
- Sunay Shah
- Vijay Kher (ORCID: https://orcid.org/0000-0003-1676-9810)
- Purav R. Bhatt
- Osvaldo Neto (ORCID: https://orcid.org/0009-0008-6584-1157)
- Muh Geot Wong (ORCID: https://orcid.org/0000-0002-7575-9877)
- Shruti Gupta (ORCID: https://orcid.org/0000-0002-5747-2151)
- Anjali Acharya (ORCID: https://orcid.org/0000-0002-5640-6881)
- Indranil Dasgupta (ORCID: https://orcid.org/0000-0002-1006-4281)
- Lin Taft
- Anjay Rastogi (ORCID: https://orcid.org/0000-0002-8117-6010)
- Ricardo Correa-Rotter
- Mai Ots-Rosenberg
- Ajay Singh (ORCID: https://orcid.org/0000-0003-2933-4058)
Institutions
- Brigham and Women's Hospital (US)
- The University of Sydney (AU)
- Albert Einstein College of Medicine (US)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Harvard University (US)
- University of Cape Town (ZA)
- University of California, Los Angeles (US)
- Jacobi Medical Center (US)
- Odense University Hospital (DK)
- Tartu University Hospital (EE)
- Groote Schuur Hospital (ZA)
- University of Warwick (GB)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Medanta The Medicity (IN)
- Sociedade de Nefrologia do Estado de São Paulo (BR)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1093/ndt/gfae273
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline